NeuroReformer® gives physical therapy and sports medicine providers a measurement-first approach to neurostimulation within active rehabilitation. The system stabilizes the waveform, performs AI-calibrated NeuroFrequency Mapping™ to define the patient’s optimal neurological and neuromuscular frequencies, then carries those frequencies into provider-directed movement.
NeuroReformer® measures the patient before active treatment begins, then carries the personalized frequencies into provider-directed movement — all inside the session you already run: treatment bay, rehab floor, or training room.
Define the patient’s optimal neurological and neuromuscular frequencies — measured from the patient, every session, never a generic preset.
Deliver those frequencies during provider-directed movement — with a built-in movement library for the selected region. Your own exercises and progressions remain yours.
When appropriate, transition onto the mapped neurological frequency without the active neuromuscular component — managing fatigue at the end of the session.
The provider selects the region and the system provides a standardized starting point for electropad placement — an efficient, screen-guided pathway for commonly treated regions.
Bioimpedance measurement while the provider evaluates the treatment region. The area with the greatest change in neurological resistance provides an objective data point for more targeted electropad placement — measurable information considered alongside examination findings and clinical judgment.
The clinician positions the electropads directly, based on the treatment objective, patient presentation, and clinical judgment — no predefined regional guide.
Tissue resistance, pad contact, position, and loading change during an active session. Adaptive NeuroFrequency Stabilization™ uses real-time feedback to help maintain signal stability as they do.
A trained provider establishes placement, initiates the workflow, controls intensity, and supervises the session. The interface handles the operational workflow; clinical decisions stay with the practitioner.
The placement strategy and treatment objective may change from patient to patient; the core measurement-first workflow stays consistent. The AI-calibrated process behind NeuroFrequency Mapping™ and the signal-stability method behind Adaptive NeuroFrequency Stabilization™ are protected by patented technology.
PT and sports medicine providers manage patients across post-operative rehab, traumatic injury, chronic pain, mobility limitations, muscle dysfunction, and return-to-activity programs. The indications below define where the technology fits — so providers and staff can explain it without extending the conversation into structural diagnoses, disease modification, or outcomes the device is not cleared to claim.
NeuroReformer® is not offered for indications beyond its cleared uses, and no individual treatment outcome is promised. It is not presented as diagnosing structural injury, repairing nerve anatomy, reversing disease progression, or guaranteeing restoration of sensation. Provider-supervised. Individual outcomes vary.
NeuroReformer® leases for $449 a month — unlimited device use; device, software, training, and support included. No five-figure capital purchase.
At an illustrative $100 per treatment session: five sessions represent $500 gross against the $449 lease, before consumables, labor, and overhead.
A treatment window that fits an existing treatment bay, rehab floor, or athletic training schedule. Actual volume depends on patients, staffing, setup, and workflow.
Adhesive electrode pads assigned to an individual patient. No separate per-treatment software charge.
Illustrative business example only. Practices establish their own pricing. Figures are not a projection or guarantee of reimbursement, patient volume, revenue, or profitability.
See what every lease includes →
“NeuroReformer® revolutionizes post-surgical recovery, achieving results once thought impossible.”
Keith Hechtman, MD — Orthopedic Sports Medicine Surgeon
We bring the technology to your practice, with the right decision-maker in the room — and your patients’ results, in real time.
Now scheduling demonstrations across Florida, expanding regionally through 2026. Outside Florida? Tell us where you are — we’ll arrange a live video demonstration and let you know when we reach your region.